Somatic Mutations, Hidden Cause of ALS and FTD Degeneration
Uncovering the Causes of ALS and FTD
Most cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) were thought to be genetically sporadic. However, the sudden and rapid progression of these diseases remains a significant challenge.
Somatic Mutations, a Localized Explosion
The research team used high-sensitivity sequencing to examine postmortem brain tissue and identified rare somatic mutations. These mutations were found to be localized to specific areas of the brain but had a profound impact on surrounding neurons, leading to widespread neurodegeneration.
The 'Somatic-Spread' Model, a New Pathology
This discovery overturns existing hypotheses and presents a 'somatic-spread' model, which explains how small genetic damage can spread to wider areas. We now understand the causal relationship between localized genetic damage and the collapse of the entire brain network.
Future Implications
If this model is proven, it may be possible to detect subtle somatic mutations at an early stage, enabling early diagnosis. Additionally, targeted therapies aimed at specific areas where mutations occur may also be developed.
Nature Genetics, Published online: 22 April 2026; doi:10.1038/s41588-026-02572-4Most cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are genetically sporadic. By detecting low-frequency somatic mutations across postmortem brains, we show that rare somatic mutations are spatially restricted to focal regions yet drive widespread degeneration. This supports a ‘somatic-spread’ model, according to which local genetic lesions initiate widespread neurodegeneration.
This study reveals the hidden genetic damage that causes degenerative diseases like ALS and FTD. By identifying high-risk areas early and developing personalized treatments, we can significantly improve the quality of life.